A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder

NCT00170755 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
718
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis